IE can occur in 39% of recipients after ITx. Viral agents are the cause in two thirds of the cases. With supportive care and appropriate treatment, resolution is possible in the majority of cases. Differentiating rejection and infection on histopathology can be difficult and relies on cultures and immunostaining.

No abstract

These results are also to be reported in brief, in a broad article by Joseph Weiss, M.D., in the Journal of the American Psychoanalytic Association, in press, and in How Psychotherapy Works: Process and Technique, by Joseph Weiss, M.D., Guilford Press, 1993. The results of the second study described in this manuscript are mentioned in a footnote in the upcoming article in JAPA, and the book. This present article is the only written description containing the methodological details of any of these two pilot studies.

We present a patient receiving chronic anticoagulant treatment with recurrent and intractable gastrointestinal bleeding due to diffuse angiodysplasia. Following failure of previous medical and surgical treatment, and in light of the patient's need for chronic anticoagulation due to mechanical heart valve, she was treated with somatostatin analogue, octreotide s.c. 100 microg on alternate days for 28 months. Treatment significantly decreased the occurrence of bleeding episodes, the need for hospitalization and blood transfusion requirements despite continued anticoagulant therapy. Octreotide treatment should be considered in patients with refractory gastrointestinal bleeding due to angiodysplasia in particular in those who need anticoagulant treatment.

with 10% H2, 10% C02, and 80% N2 at 37°C. Concentrated and diluted cell suspensions were made by using the same medium without added carbohydrate.Animal inoculation and determination of im-203 on July 31, 2020 by guest http://iai.asm.org/ Downloaded from 204 VAN HOUTE, UPESLACIS, AND EDELSTEIN